|
Index of reports
> Cases with Hypotension (88)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include hypotension. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 88 Next >>
Possible Cytarabine side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male, weighing 95.8 kg (210.8 pounds)
Reactions: Abdominal Pain, Hypotension, Pancytopenia, Ascites, Faecaloma, Diarrhoea, Sepsis, Colitis, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 25 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-04
Clofarabine
Dosage: 25 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-03
Cytarabine
Dosage: 750 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-04
Cytarabine
Dosage: 750 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-03
Idarubicin HCL
Dosage: 7.5 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-02
Idarubicin HCL
Dosage: 7.5 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-01
Other drugs received by patient: Vancomycin; Metronidazole; Piritramide; Enoxaparin Sodium; Zofran; Clonazepam; Sodium Chloride; Ciprofloxacin; Acyclovir; Ringer; Levothyroxine Sodium; Potassium Chloride; Ceftazidime; Noxafil
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate Sodium
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male, weighing 78.0 kg (171.6 pounds)
Reactions: Pain in Extremity, Hypotension, Splenic Infarction, Paraesthesia, Septic Embolus, Fungal Test Positive, Hypoxia, Circulatory Collapse, Asthenia, Cough
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg, intrathecal
End date: 2012-07-12
Daunorubicin HCL
Dosage: 200 mg
End date: 2012-08-02
Methotrexate
Dosage: 30 m, intrathecal
End date: 2012-08-09
PEG-L-Asparaginase (Pegaspargase, Oncospar)
Dosage: 4900 iu, intravenous
End date: 2012-07-15
Prednisone
Dosage: 3360 mg, oral
Administration route: Oral
End date: 2012-08-08
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-08-21
Patient: male, weighing 13.6 kg (29.9 pounds)
Reactions: Contusion, Vomiting, Flatulence, Hypotension, Tachycardia, Gastrointestinal Necrosis, Cardio-Respiratory Arrest, Hypophagia, Abdominal Distension, Bacterial Test Positive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: it 2-2.99 yrs 50 mg
Dexamethasone TAB
Dosage: po 3 mg/m2 dose (1.75 bid)
Administration route: Oral
Methotrexate Sodium
Dosage: it 2 mg/m2
PEG-L Asparaginase (Pegaspaegase, Oncospar)
Dosage: iv 2500 units/m2
Vincristine
Dosage: iv 1.5mg/m2 on day 1 and day 8
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-20
Patient: female, weighing 70.8 kg (155.8 pounds)
Reactions: Abdominal Pain, Hyperpyrexia, Anaphylactic Reaction, Chills, Pain, Hepatic Failure, Transaminases Increased, Splenic Infarction, Loss of Consciousness, Aortic Thrombosis, Off Label Use, Malaise, C-Reactive Protein Increased, Myositis, Dyspnoea, Hypotension, Arrhythmia, Lung Consolidation, Hypophosphataemia, Zygomycosis, Bacteraemia, Ventricular Tachycardia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Shock, Infusion Related Reaction
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cytarabine
Dosage: day 1,8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
Decadron Phosphate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
Doxil
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Methotrexate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-01-01
PEG-Asparaginase
Dosage: day 2, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-25
End date: 2007-10-25
Velcade
Dosage: day 1, 4, 8 and 11
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Vincristine
Dosage: day 1,8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin
Possible Cytarabine side effects in 14 year old male
Reported by a physician from United States on 2012-08-20
Patient: 14 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Dyspnoea, Hypotension, Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-10
Cytarabine
Dosage: 70 mg, cyclic
Start date: 2012-08-09
End date: 2012-08-09
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-16
Patient:
Reactions: Off Label Use, Hypotension, Hypertension
Drug(s) suspected as cause:
Bortezomib
Dosage: per dose on days 1, 4, 8 and 11
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 or days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: per day divided into 2 doses was given orally for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: on day 15 or days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Dosage: 2500 units/m2/dose was given intramuscularly as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: per dose (2 mg maximum dose) was administered intravenously by push on day 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-14
Patient:
Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-14
Patient: female, weighing 70.8 kg (155.8 pounds)
Reactions: Abdominal Pain, Rhabdomyolysis, Hyperpyrexia, Chills, Anaphylactic Reaction, Bone Pain, Hepatic Failure, Transaminases Increased, Loss of Consciousness, Aortic Thrombosis, Splenic Infarction, Hypokalaemia, Malaise, C-Reactive Protein Increased, Dyspnoea, Hypotension, Hypophosphataemia, Zygomycosis, Bacteraemia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Lung Infiltration, Shock, Infusion Related Reaction
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-10-23
Decadron Phosphate
Dosage: 9 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Methotrexate Sodium
Dosage: unk, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-01-01
Pegaspargase
Dosage: unk, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-25
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Vincristine
Dosage: 2 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-13
Patient: female, weighing 55.0 kg (121.0 pounds)
Reactions: Disseminated Intravascular Coagulation, Hypotension, Continuous Haemodiafiltration, Pyrexia, Tumour Lysis Syndrome, Respiratory Failure, Acute Respiratory Distress Syndrome, Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 157 mg
Daunorubicin HCL
Dosage: 80 mg
Etoposide
Dosage: 15.7 mg
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-13
Patient: female, weighing 64.6 kg (142.1 pounds)
Reactions: Pulmonary Haemorrhage, Blood Culture Positive, Tachycardia, Hypotension, Bacterial Infection, Pyrexia, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 17000 mg
End date: 2012-07-25
Etoposide
Dosage: 1275 mg
End date: 2012-07-25
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-08-09
Patient: male, weighing 31.8 kg (70.0 pounds)
Reactions: Abdominal Pain, Atelectasis, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Activated Partial Thromboplastin Time Prolonged, Multi-Organ Failure, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Alanine Aminotransferase Increased, Hypotension, Hypercalcaemia, Respiratory Failure, Embolism, Cardiac Failure, Aspartate Aminotransferase Increased, Ventricular Tachycardia, Ejection Fraction Decreased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ativan
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: 100 mg/kg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-11
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Fentanyl
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-01
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-06
Patient: female, weighing 64.6 kg (142.1 pounds)
Reactions: Hypotension, Tachycardia, Bacterial Infection, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 17000 mg
End date: 2012-07-25
Etoposide
Dosage: 1275 mg
End date: 2012-07-25
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-02
Patient: female, weighing 11.1 kg (24.4 pounds)
Reactions: Hypotension, Neoplasm Progression, Tumour Compression, Hepatitis, Chloroma, Pseudomonas Test Positive, Respiratory Failure, Cholangitis, Intracranial Pressure Increased, Hydrocephalus, Hypertension
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 2948 mg
End date: 2011-11-01
Mitoxantrone Hydrochloride
Dosage: 4 mg
End date: 2011-11-08
Possible Cytarabine side effects in 24 year old female
Reported by a consumer/non-health professional from United States on 2012-07-30
Patient: 24 year old female, weighing 51.0 kg (112.2 pounds)
Reactions: Abdominal Pain, Hyperkalaemia, Disseminated Intravascular Coagulation, Gastrointestinal Necrosis, Acidosis, Nephrolithiasis, Skin Discolouration, Ecchymosis, Clostridial Infection, Emphysema, White Blood Cell Count Decreased, Hypotension, Anaemia, Condition Aggravated, Soft Tissue Infection, Sepsis, Flank Pain, Colitis, Cardiac Arrest, Sinus Tachycardia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: last dose on 16jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Cytarabine
Dosage: last dose:17jun12 route:intra ommya
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Dexamethasone
Dosage: last dose:16jun12
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Doxorubicin HCL
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Filgrastim
Dosage: last dose:18jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
End date: 2012-01-01
Leucovorin Calcium
Dosage: last dose :21may12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Mesna
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Methotrexate
Dosage: last dose:13jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Methylprednisolone
Dosage: last dose:21may12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Sprycel
Dosage: last dose on 26jun12
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Vincristine Sulfate
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-07-26
Patient: female, weighing 11.1 kg (24.4 pounds)
Reactions: Hyperbilirubinaemia, Respiratory Failure, Cholangitis, Blood Culture Positive, Hypotension, Pseudomonas Infection, Hydrocephalus, Hepatitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 2948 mg
End date: 2011-11-01
Mitoxantrone Hydrochloride
Dosage: 4 mg
End date: 2011-11-08
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-07-26
Patient: male, weighing 13.9 kg (30.6 pounds)
Reactions: Capillary Nail Refill Test Abnormal, Tachycardia, Anaphylactic Reaction, Hypotension, Drug Hypersensitivity, Pyrexia, Respiratory Distress
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 7200 mg
Elspar
Dosage: 3600 unit
End date: 2012-07-18
Possible Cytarabine side effects in 17 year old male
Reported by a physician from United States on 2012-07-26
Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)
Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Pulmonary Oedema, Acute Respiratory Distress Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: 1000 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-27
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Daunorubicin Hydrochloride
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-26
Possible Cytarabine side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-26
Patient: male, weighing 27.7 kg (60.9 pounds)
Reactions: Acute Pulmonary Oedema, Hypotension, Tachycardia, General Physical Health Deterioration, Respiratory Distress, Ascites, Heart Rate Decreased, Pleural Effusion, Septic Shock, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg
Dexamethasone
Dosage: 78 mg
Methotrexate Sodium
Dosage: 15 mg
Oncaspar
Dosage: 2500 iu
Vincristine Sulfate
Dosage: 3 mg
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-07-24
Patient: male, weighing 31.8 kg (70.0 pounds)
Reactions: Atelectasis, Abdominal Pain, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Multi-Organ Failure, Activated Partial Thromboplastin Time Prolonged, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Hypotension, Alanine Aminotransferase Increased, Hypercalcaemia, Embolism, Cardiac Failure, Respiratory Failure, Ventricular Tachycardia, Ejection Fraction Decreased, Aspartate Aminotransferase Increased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ativan
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-11
Cytarabine
Dosage: 100 mg/kg, bid
Start date: 2012-06-01
End date: 2012-06-03
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Fentanyl
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-01
Possible Cytarabine side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-17
Patient: male, weighing 31.8 kg (70.0 pounds)
Reactions: Abdominal Pain, Acidosis, Pericardial Effusion, Left Ventricular Dysfunction, Hypocalcaemia, Renal Failure Acute, Pneumonitis, Dyspnoea, Angina Pectoris, Hypotension, Anaemia, Delirium, Tumour Lysis Syndrome, Respiratory Failure, Cardiac Failure, Aspartate Aminotransferase Increased, Ejection Fraction Decreased, Sinus Tachycardia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ativan
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: 100 mg/kg, bid
Start date: 2012-06-01
End date: 2012-06-03
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-11
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Fentanyl
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-01
Possible Cytarabine side effects in
Reported by a physician from United Kingdom on 2012-07-17
Patient:
Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-07-16
Patient: male, weighing 27.7 kg (60.9 pounds)
Reactions: Hypotension, Tachycardia, Respiratory Distress, Heart Rate Decreased, Pulmonary Oedema, Septic Shock, Oxygen Saturation Decreased, Pulseless Electrical Activity
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg
Dexamethasone
Dosage: 78 mg
Methotrexate
Dosage: 15 mg
PEG-L-Asparaginase (Pegaspargase, Oncospar) 2500 IU
Dosage: 2500iu
Vincristine
Dosage: 3 mg
Possible Cytarabine side effects in
Reported by a physician from United Kingdom on 2012-07-10
Patient:
Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir
Possible Cytarabine side effects in 17 year old male
Reported by a physician from United States on 2012-07-09
Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)
Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Acute Respiratory Distress Syndrome, Pulmonary Oedema
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: 100 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: 1000 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Daunorubicin Hydrochloride
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-26
Possible Cytarabine side effects in
Reported by a health professional (non-physician/pharmacist) from China on 2012-07-02
Patient:
Reactions: Hypotension, Bone Marrow Failure, Rash, Diffuse Large B-Cell Lymphoma, Herpes Zoster, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: at day 8
Bortezomib
Dosage: day 1 (12 hr before chemotherapy)
Indication: Diffuse Large B-Cell Lymphoma
Carboplatin
Indication: Diffuse Large B-Cell Lymphoma
Cisplatin
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Daunorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Dexamethasone
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Ifosfamide
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-06-28
Patient: female, weighing 44.5 kg (97.9 pounds)
Reactions: Hypotension, Pyrexia, Abdominal Pain Upper, Candida Test Positive, Simplex Virus Test Positive, Diarrhoea, Fungal Test Positive, Skin Lesion, Neutropenia, Klebsiella Test Positive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg
Methotrexate
Dosage: 15 mg
Methylprednisolone
Dosage: 813.75 mg
PEG-L-Asparaginase (K-H)
Dosage: 3225 unit
Vincristine Sulfate
Dosage: 3.88 mg
Possible Cytarabine side effects in male
Reported by a physician from Spain on 2012-06-18
Patient: male, weighing 85.6 kg (188.3 pounds)
Reactions: Sepsis, Tachycardia, Hypotension, Pyrexia, Anuria
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 200 mg/m2;
Indication: non-Hodgkin's Lymphoma
Start date: 2011-11-03
Cytarabine
Indication: non-Hodgkin's Lymphoma
Etoposide
Indication: non-Hodgkin's Lymphoma
Melphalan Hydrochloride
Indication: non-Hodgkin's Lymphoma
Other drugs received by patient: Cefepime; Filgrastim; Nistatin; Potassium Chloride; Potassium Chloride; Linezolid; Metoclopramide; Omeprazole; Alprazolam; Dexchlorpheniramine Maleate; Loperamide; Teicoplanin; Tramadol HCL; Betametasona; Diazepam; Furosemide; Meropenem; Potassium Chloride; Potassium Chloride; Vitamin K TAB; Acetaminophen; Potassium Chloride; Acyclovir; Butylscopolaminiumbromid; Fluconazole; Ondansetron; Allopurinol; Pyridoxine HCL
Possible Cytarabine side effects in 53 year old female
Reported by a physician from United States on 2012-06-15
Patient: 53 year old female, weighing 60.6 kg (133.3 pounds)
Reactions: Hypotension, Pneumonia Cytomegaloviral
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-04-05
Cytarabine
Dosage: 4gm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-04-06
Dexamethasone
Dosage: 40mg every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-04-05
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-04-05
Page 1 Next >>
|
